Author： Schulz Charles Haight Robert J
Publisher： Informa Healthcare
ISSN： 1474-0338
Source： Expert Opinion on Drug Safety, Vol.12, Iss.5, 2013-09, pp. : 777-782
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Olanzapine is beneficial for adolescents with schizophrenia
Inpharma, Vol. 1, Iss. 1541, 2006-01 ,pp. :
Access to resources
Recommend
Hyperglycaemia in adolescents receiving clozapine or olanzapine
Inpharma, Vol. 1, Iss. 1317, 2001-01 ,pp. :
Drug safety evaluation of olanzapine pamoate
By Schöttle Daniel Kuhnigk Olaf Naber Dieter
Expert Opinion on Drug Safety, Vol. 12, Iss. 6, 2013-11 ,pp. :
Olanzapine: In Adolescents with Schizophrenia or Bipolar I Disorder
CNS Drugs, Vol. 24, Iss. 5, 2010-05 ,pp. :
Olanzapine/risperidone not for use in elderly with dementia
Inpharma, Vol. 1, Iss. 1429, 2004-01 ,pp. :